Amy Piccioli, a Los Angeles mother of three, faced a terrifying reality when a routine ER visit for suspected dehydration revealed a hidden enemy within her body. A CT scan unveiled a mass in her colon and alarming lesions on her liver – a stage 4 colorectal cancer diagnosis, despite experiencing absolutely no symptoms.
The shock was profound. “I had no symptoms,” Amy recalled, a chilling testament to the silent nature of the disease. “I’m very attuned to my body, so to have this happen without any warning signs was just shocking.” Suddenly, her life was consumed by fear and the daunting prospect of a long, uncertain battle.
Initial treatment involved a grueling combination of chemotherapy and immunotherapy. Hope flickered when scans showed the tumors shrinking, leading to surgery to remove the primary tumor in her colon. But the cancer’s widespread presence in her liver presented a far more complex challenge.
Traditional treatments offered only a temporary reprieve, a relentless cycle of shrinking tumors only to have new ones emerge. Doctors explained that a liver transplant offered the only real chance for a long-term solution, a path rarely taken for colorectal cancer in the United States.
The possibility seemed remote, requiring extraordinary effort to pursue. Fortunately, Amy’s medical team discovered a specialized program at Northwestern Medicine in Chicago, offering liver transplantation for metastatic colorectal cancer patients. This program meticulously evaluates patients, seeking those whose cancer biology suggests a strong potential for success.
The transplant’s success hinged on finding a living donor. Amy bravely shared her need with loved ones, and a childhood friend, Lauren Prior, stepped forward. After rigorous screening, Lauren was confirmed as a perfect match, offering Amy a lifeline she desperately needed.
In December 2025, history was made. Amy became the first patient at Northwestern to receive a living donor liver transplant for metastatic colon cancer. The surgery was a success, marking a turning point in her fight for survival.
Recovery wasn’t easy, but Amy’s resilience shone through. Within weeks, she was regaining her strength, returning to a normal life, and even resuming her workouts. Three months post-transplant, she felt completely renewed, a testament to the body’s incredible capacity for healing.
Then came the moment of truth: her first post-transplant blood screening. The results were astonishing – no evidence of cancer remained. “So I have no evidence of disease currently,” she shared, a wave of relief washing over her.
Amy’s story serves as a powerful reminder of the insidious nature of early-onset colorectal cancer, often “silent” and undetectable through routine screening before age 45. Subtle symptoms and tumors in hard-to-reach locations can delay diagnosis, emphasizing the importance of vigilance.
She urges everyone to prioritize their health, heed any changes in their bodies, and diligently follow recommended screening guidelines. “You have to be the captain of your own ship,” Amy emphasizes, a message born from her own courageous journey and unwavering determination.
